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Abstract 
Hepatitis B Virus (HBV) and Hepatitis C Virus (HCV) infections lead to chronic diseases and 
are the most common causes of liver cirrhosis and cancer in developing countries like Nepal. 
The study is carried out to determine the seroprevalence of HBV and HCV by using a Rapid 
kit method and Elisa Method to find out its risk factors. The cross-sectional study was done 
among blood donating people from 16th August 2016 to 19th November 2016. Blood donors in 
Pokhara Valley were screened for anti-HCV antibodies, anti-HBV antibodies using third 
generation ELISA kits and automated ELISA Processor in serology laboratory at Central Blood 
Transfusion Service (CBTS) of Nepal Red Cross Society (NRCS) in Pokhara, Nepal. 1777 
(87.2%) units were male blood donors and 260 (12.6%) units were female donors out of 2037 
participants.  Gender wise, the ratio between male and female was 1:0.1. HBV and HCV 
infection rate in blood donors were detected at 0.7% (15/2037) and 0.5% (8/2037) respectively. 
HBV infection rate in volunteer blood donor people was 0.7% (14/1881) which was higher 
than the replacement donors i.e. 0.6% (1/156). Similarly, in HCV infection rate in volunteer 
donor were 0.4% (8/1881). HBV infected people are detected higher than the HCV infected 
people among the blood donors.  In addition, there was no significant relationship between 
positive results of HBV and HCV tests with the gender, age, tattoo, donor type. 
Keywords:   Blood transfusion, Sera, HCV, HBV, ELISA, Nepal 
*Corresponding Author 
Email: balkrishna_bhattachan@hotmail.com 
Introduction  
Hepatitis B virus (HBV) is an enveloped, 
hepadnaviridae with partially double-stranded 
DNA [1].  It is one of the cause of potentially life-
threatening liver infection and is a major global 
health problem. It can cause chronic liver disease 
and puts people at high risk of death from 
cirrhosis of the liver and liver cancer [2]. 
Worldwide, an estimated two billion people have 
been infected with the Hepatitis B virus and 
more than 240 million have chronic (long-term) 
liver infections. In developing countries like 
Nepal, The highest prevalence of HBV was found 
in the 6-15 year age group [3]. Common modes of 
transmission include perinatal, unsafe injection 
practices, unsafe blood transfusions, and 
unprotected sexual contact [4]. 
Hepatitis C virus (HCV) is single-stranded RNA, 
enveloped flavivirus that causes liver disease [5]. 
The disease can range in severity from a mild 
illness lasting for few weeks to a serious, life-
threatening condition that can lead from cirrhosis 
of the liver to liver cancer. About 170 million 
people are infected worldwide [6].  HCV is most 
commonly transmitted through exposure to 
infectious blood and it may be transmitted 
through gender with an infected person or 
sharing of personal items contaminated with 
infectious blood, but these are less common [7]. 
This study is conducted among blood donors in 
Pokhara Valley in order to study the HBV and 
HCV seroprevalence, among different groups 
and subgroups of blood donors. The main aim of 
this study is to determine the seroprevalence of 
HBV and HCV by Rapid kit and ELISA Method 
and find out its associated risk factors. Open land 
route facilitates the biological and virological 
spread of diseases [8]. So, in the case of HCV and 
HBV, millions of migrant workers act as a 
biological transporter. However, documentation 
of HCV and HBV with past infection is frequent 
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in person with routine parenteral exposures 
which indicate that the transmission by this line 
is prominent. Accidental parenteral exposures 
such as needle-stick injuries are quite common in 
patients. Another route of transmission is having 
tattoos, drug addicts, heterosexual and 
homosexual gender, liver diseases, and blood 
transfusion. Perception and awareness level of 
people has been changed after the jaundice 
outbreak occurred in Biratnagar during April-July 
2014 [9]. 
Methods and Materials 
Study Design and setting  
Cross-sectional and descriptive type of study was 
done. The study sample comprised of 2037 blood 
donors. Healthy donors included in this study 
were donating blood in Blood Transfusion 
Center, Pokhara at mobile health camp organized 
by Red Cross Society. This study was conducted 
from 16th August to 19th November 2016.  
Study Area and Population 
Blood donors were selected according to the 
criteria of Blood Transfusion Service (BTS) based 
on the National Guidelines for BTS. The 
categories of donors that were present in this 
study were volunteers and replacement who may 
be the first time or repeated donor. Individuals 
selected by donor screening criteria as per NRCS’ 
Standard Operating Procedure (SOP) of 2006 AD. 
Participants were requested to fill a questionnaire 
form along with written consent were collected. 
Each donor was given an ID number for later 
trace out if needed. 
Inclusion criteria: Healthy donors were included 
for blood donation after taking an interview. The 
detailed inclusion criteria for blood donors are:- 
donor should be in the age group between 18 to 
60 years, body weight more than 45 kg for male 
and 35 kg for female, within normal range blood 
pressure 120/80 mm without medication and 
Hemoglobin should not be less than 12.6 g/ml.  
Exclusion criteria: Those who are found 
unhealthy on the interview were excluded for 
donation. The exclusion criteria for blood donors 
are:- in the case of a female, menstruating, 
pregnant and breastfeeding mother are not 
allowed for donation and Patients taking 
antibiotics.  
Sample collection and processing  
The blood bags were transported from blood 
donation campaign site to blood bank in igloo 
box containing ice bars to maintain the 
temperature near 40C. A few drops of blood is 
used for blood grouping and 5ml of blood was 
allowed to clot or centrifuged at 3000 RPM for 2 
minutes in a dry screw-capped test tube to 
separate serum samples to perform the test for 
HBV and HCV. 
Detection of HBV and HCV by using 
Rapid kit test  
Collected Sera were subjected for routine 
mandatory screening for HBsAg and anti-HCV 
antibodies by enzyme immunoassay-based rapid 
tests according to the standard protocol 
described by respective company (Hepacard, J. 
Mitra and Co., New Delhi, India, and HCV TRI-
DOT, J. Mitra and Co., New Delhi, India) [10]. 
Detection of HBV and HCV by using 
ELISA method 
Sera from blood donors for HCV were tested 
against  (anti-HCVs)  antigen by third generation 
enzyme-linked immunosorbent assay (ELISA) 
and for detection of HBV by HBsAg ELISA (HCV 
TRI-DOT Test, J. Mitra and Co., New Delhi, 
India; Hepacard, J. Mitra; Genedia HCV 
ELISA.3.0, Green Cross, Kyunggido, Korea; and 
Enzygnost HBsAg 5.0, Dade Behring, Marburg, 
Germany) [11]. 
Statistical Analysis  
Pearson's Chi-square test was used to determine 
the significant association of dependable 
variables. WinPepi software (version 11.65) was 
used for quantitative data analysis. A p-value < 
0.05 was considered to be statistically significant 
at 95 % CI. 
Results  
A total of 2037 blood samples were collected 
from donors. The blood was screened by Rapid 
test and ELISA test to detect HBV and HCV 
infection. Gender wise, the ratio between male 
and female was at 1:0.1. The infection rate of 
HBV and HCV in blood donors were detected to 
be 0.7 % (15/2037) and 0.5% (8/2037) 
respectively (Figure 1). 
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Figure 1: Infection of Hepatitis B Virus and Hepatitis C 
Virus in blood donors (Confirm by ELISA Method) 
The infection rate in a male for HBV is 0.7% 
(13/1777) which was higher than HCV 0.4% 
(8/1777). Similarly, the infection rate in the 
female for HBV is 0.7% (2/260) which was also 
higher than HCV (0.0%) but no statistically 
significant, (p=0.280) result was obtained (Table 
1). 
In HBV, the highest rate of infection was detected 
0.9% (7/764) in 31-45 year old of blood donors 
which was followed by 0.7 % (1/138) in 46-60 
year old, and 0.6% (7/1135) in 18-30-year-old 
people. Similarly, the highest rate of HCV 
infection were detected 0.7% (1/138) in 46-60 
years old people followed by 0.6% (5/764) in 31-
45-year-old and 0.2% (2/1135) in 18-30 years old 
people, P=0.588, (Figure 2) 
Figure 2.  Age wise distribution with HBV and HCV 
among blood donors 
HBV infection rate of volunteer donor people 
was 0.7% (14/1881), which is higher than the 
replacement donor 0.6% (1/156). Similarly, HCV 
infection rate of volunteer donor was 0.4% 
(8/1881) with p=0.455 (Table 2). 
Table 2: Donor type-wise distribution with hepatitis 
infections among blood donors 
Donor type Disease Total 
No. 
p-
value 
 HBV 
No. (%) 
HCV 
No. (%) 
  
Replacement 
Donor 
1 (0.6) 0 (0.0) 156 0.455 
Volunteer 
Donor 
14(0.7) 8 (0.4) 1881  
Total 15 (0.7) 8 (0.4) 2037  
HBV infection rate in people without tattoo was 
0.7% (14/1847) higher than the people with tattoo 
0.5% (1/190). Similarly, HCV infection rate in 
people without tattoo was 0.3% (6/1847) higher 
than 0.1% (2/190) in people with a tattoo with 
p=0.214 (Table 3). 
HBV infection rate of married blood donors was 
0.9% (12/1262) whereas 0.3% (3/775) was found 
in unmarried blood donors. Similarly, HCV 
infection rate of married blood donors was 0.7% 
(7/1262) whereas 0.1% (1/775) was found in 
unmarried blood donor with p=0.65 (Table 4). 
Table 4.  Marital status wise distribution with 
hepatitis infection among blood donors 
 Disease 
Total p-value Marital 
status  
HBV  
No. (%) 
HCV 
No. (%) 
No 3 (0.3) 1 (0.1) 775 0.651 
Yes 12 (0.9) 7 (0.7) 1262  
Total 15 (0.7) 8 (0.4) 2037  
Discussion  
The group of viruses (Hepatitis A, B, C, D, and E) 
that cause acute and/or chronic infection and 
inflammation of the liver give rise to a major 
public health problem globally [12]. Hepatitis B 
and C viruses are major agents of severe illness 
and death. The burden of acute hepatitis, liver 
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Table 1: Sex-wise distribution with Hepatitis diseases 
among blood donors 
Gender Hepatitis Total No. p-
value 
 HBV  
No. (%) 
HCV 
No. (%) 
  
Male 13 (0.7) 8 (0.4) 1777 
0.280 Female 2 (0.7) 0 (0.0) 260 
Total 15 (0.7) 8 (0.4) 2037 
Table 3. Tattoo wise distribution with hepatitis 
infection among blood donors 
 Disease 
Total p-value Tattoo 
used 
HBV 
No. (%) 
HCV 
No. (%) 
No 14 (0.7) 6 (0.3) 1847 0.214 
Yes 1 (0.5) 2 (0.1) 190  
Total 15 (0.7) 8 (0.4) 2037  
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cirrhosis and cancer due to this Hepatitis B and C 
Viruses is high worldwide (about 2.7% of all 
deaths) and is forecasted to become a higher 
ranked cause of death over the next two decades. 
It is estimated that 57.0% of cases of liver 
cirrhosis and 78.0% of cases of primary liver 
cancer have resulted from hepatitis B or C virus 
infection [13]. 
The infection rate of HBV and HCV in blood 
donors were detected on 0.7% and 0.5% 
respectively. In the previous study reported that 
the hepatitis B and hepatitis C infection rate was 
detected by 2.6% and 0.3% respectively out of 307 
tested patients [14]. The high percentage of HBV 
and HCV infection was obtained may be due to 
less no. of public awareness of hepatitis known 
infected person did not participated in the blood 
donation. The unsafe behavioral practices such as 
body pierce, tattoo, use of injectable drug, 
unprotected sex etc.  also led to increase the 
transmission of infection. The positive rate of 
hepatitis infection was found to be higher in a 
male patient than female but there is no statistical 
significant relationship found between gender 
and hepatitis [14]. In HBV infection, most of the 
infection rate (0.9%) was detected in age group 
ranging 31-45 years old whereas most of the 
infection rate in 46-60 years old people in HCV 
was detected at 0.7%. The highest positive rate 
was found in the patients of age group 31-60 
years old [14]. The infection rate of HBV and 
HCV in volunteer donor people were found to be 
0.7%, and 0.4% respectively. It may be, due to 
blood transfusion, hepatitis can be transmitted in 
another body. Study also revealed that the 
eastern region of Nepal had the highest 
percentage of HCV infection (48.0%) [15]. 
Seroprevalence of HBV among mothers were 
found 17.9% in 151 mothers of the total study 
population in the selected Village Development 
Committees (VDCs) [16]. The highest rates of 
HCV and HBV co-infection was found to be 58% 
and 70% respectively 30-39 years age group.  
HBV infection rate was 0.7% higher in people 
without tattoo whereas the HCV infection rate in 
people without tattoo was 0.3% higher. Because 
in our case, the number of participants without 
tattoo was higher than the number of blood 
donors with tattoo. Although, it is widely known 
fact that cosmetic procedure, tattooing on a body 
can result in a HBV and HCV infection if the 
needles and equipment used are not properly 
sanitized. Besides, the poor tattooing procedure 
may have chances of microbial contamination. 
HBV and HCV infection rate in married blood 
donors were 0.9% and 0.7% respectively. 
Researchers concluded the marital status is a 
significant risk factor [18]. They detected HBV 
and HCV were found 1.7% and 1.0% respectively 
in a married participant. HBV and HCV can be 
transferred from unprotected sexual contact if 
their partner is infected with the hepatitis virus. 
People with unsafe sexual relationships and 
addiction to injectable drug users should always 
be careful as the chances of the virus getting 
transmitted are high among them. 
This severity of cases may be due to the lack of 
vaccination information in the population. The 
replication of HBV and HCV in HIV patients 
should be actively monitored while receiving 
antiviral therapy and this monitoring system 
should be made a part of clinical care [17]. In the 
context of Nepal, people have has less 
knowledge of vaccination and those who knows 
avoid it because of hepatitis vaccination cost and 
no. of clinic visits to complete vaccination doses. 
The implications of screening tests for HBV or 
HCV co-infection in HIV patients are of great 
need in Nepal [18]. 
Limitations of the study: 
This study was carried out in a limited 
population and only involved the donors 
attending on Mobile Health camp organized by 
BTS-NRS. So, the results obtained from this study 
might not be enough to indicate the actual 
burden of the disease in the large population. 
Still, the study found the existence of endemic 
viral hepatitis among the people and need health 
policies to reduce the burden of viral hepatitis in 
society. PCR based detection method was not 
incorporated due to feasibility issues regarding 
time and resources constrain. 
Conclusions 
HBV and HCV infections can be transfer by 
piercing needles, general contact, blood 
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transfusion, drug users. Therefore, policymaker 
should provide awareness and knowledge for 
people about it. General people must take a 
hepatitis vaccine. Government should provide 
hepatitis vaccine at an affordable price. 
Government and its allied body should provide 
infection control support. Finally, people should 
be aware of its associated risk factors. The 
infection rate in prior blood transfusion people, 
HBV and HCV infections found in the same ratio.  
Moreover, due to its risk factors, like age, gender, 
tattoo, marital status, donor type can be 
transmitted the vital role in the mode of 
transmission of hepatitis. 
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